Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.447 SEK | -4.89% | -0.67% | -14.53% |
Apr. 16 | Mendus AB Announces Board Changes | CI |
Mar. 27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
43.75M | - | - | - | - | - | |
49.18B | - | |||||
42.11B | ||||||
40.37B | ||||||
28.85B | ||||||
26.09B |
- Stock Market
- Equities
- IMMU Stock
- Charts Mendus AB
- Sector Chart